Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Apogee Therapeutics, Inc. APGE

Set alert

Price alert · APGE

All alert types
135.07 USD 0.00 0.00%

At close · Sep 2

132.55 -2.52 -1.87%

After hours · Sep 2, 4:00 PM ET

Bid
132.62 × 2
Ask
132.64 × 2
135.06 Day range 135.09
52.34 52-week range 135.09
YTD
+78.95%
1 year
+208.31%
Open
135.06
Prev close
135.07
Mkt cap
8.40B
Vol
0
Avg vol
1.39M
EPS
-4.34
P/E
0.00
Div yield
0.00%
More statistics
Low
135.06
High
135.09
Forward P/E
-26.00
Beta
0.33
Short ratio
3.63
Inst. own
110.80%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
134.18
200-d avg
93.12
1y target
134.62

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 10, 2026Earnings: -1.14; estimate -1.07; surprise -6.54%
  • Aug 12, 2026Downgrade: BTIG · Buy → Neutral
  • Aug 13, 2026Rating: Truist Securities · Hold → Hold
Signals (62)
NameDateAgo
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 31, 20262 months ago
RSI: OverboughtAug 28, 20262 months ago
SMA: BearishAug 27, 20262 months ago
MACD: Sell SignalAug 27, 20262 months ago
RSI: OverboughtAug 26, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 21, 20262 months ago
MACD: Sell SignalAug 21, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 20, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Buy SignalAug 14, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 12, 20262 months ago

Newest 20 of 62.

Analyst view

Consensus: hold

Hold
Price target (mean) 134.62 -0.3% downside
Target (low)
133.00
Target (mean)
134.62
Target (high)
135.11
Ratings (0m) 7 1 buy · 6 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold6
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 15
  • 2 months ago 15
  • 3 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

APGE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.25-1.27 – -1.23-1.11-12.6%00.0%2
Next quarter-1.37-1.40 – -1.34-1.03-33.0%00.0%2
Current year-4.86-4.93 – -4.79-4.22-15.2%00.0%2
Next year-5.20-5.87 – -4.36-4.86-6.9%7.14M0.0%6

Upgrades and downgrades

The latest rating changes

APGE analyst upgrades and downgrades
DateFirmActionFromTo
Aug 13, 2026Truist SecuritiesMaintainedHoldHold
Aug 12, 2026BTIGDowngradeBuyNeutral
Jun 24, 2026StifelDowngradeBuyHold
Jun 24, 2026TD CowenDowngradeBuyHold
Jun 24, 2026GuggenheimDowngradeBuyNeutral
Jun 24, 2026MizuhoDowngradeOutperformNeutral
Jun 23, 2026Deutsche BankDowngradeBuyHold
Jun 23, 2026CitigroupDowngradeBuyNeutral
Jun 23, 2026RBC CapitalMaintainedSector PerformSector Perform
Jun 23, 2026UBSDowngradeBuyNeutral
Jun 23, 2026WedbushDowngradeOutperformNeutral
Jun 22, 2026Canaccord GenuityDowngradeBuyHold
Jun 8, 2026RBC CapitalMaintainedSector PerformSector Perform
May 27, 2026Truist SecuritiesMaintainedHoldHold
May 27, 2026BTIGReiteratedBuyBuy
May 27, 2026WedbushMaintainedOutperformOutperform
May 1, 2026Rothschild & CoInitiated—Buy
Mar 30, 2026MizuhoMaintainedOutperformOutperform
Mar 24, 2026CitigroupMaintainedBuyBuy
Mar 24, 2026Canaccord GenuityMaintainedBuyBuy
Mar 24, 2026GuggenheimMaintainedBuyBuy
Mar 23, 2026BTIGReiteratedBuyBuy
Mar 18, 2026Truist SecuritiesInitiated—Hold
Mar 16, 2026BTIGReiteratedBuyBuy
Mar 3, 2026RBC CapitalMaintainedSector PerformSector Perform
Mar 3, 2026WedbushMaintainedOutperformOutperform
Jan 22, 2026RBC CapitalDowngradeOutperformSector Perform
Jan 7, 2026Wolfe ResearchInitiated—Peer Perform
Jan 6, 2026BTIGMaintainedBuyBuy
Jan 5, 2026BTIGMaintainedBuyBuy